Generalized glucocorticoid resistance
Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD's weight loss doctor NYC
Philadelphia GLP-1 weight loss and GLP-1 clinic NYC
| Generalized glucocorticoid resistance | |
|---|---|
| File:Glucocorticoid receptor.png | |
| Synonyms | Primary generalized glucocorticoid resistance, Chrousos syndrome |
| Pronounce | N/A |
| Specialty | N/A |
| Symptoms | Fatigue, hypertension, hypokalemia, hirsutism, irregular menstruation |
| Complications | Adrenal hyperplasia, metabolic syndrome |
| Onset | Variable |
| Duration | Lifelong |
| Types | N/A |
| Causes | Mutations in the glucocorticoid receptor gene |
| Risks | Family history |
| Diagnosis | Genetic testing, hormone level tests |
| Differential diagnosis | Cushing's syndrome, Addison's disease |
| Prevention | N/A |
| Treatment | Mineralocorticoid receptor antagonists, androgen receptor antagonists, glucocorticoid therapy |
| Medication | Spironolactone, eplerenone, dexamethasone |
| Prognosis | N/A |
| Frequency | Rare |
| Deaths | Not directly fatal |
Generalized glucocorticoid resistance, also known as Chrousos syndrome, is a rare genetic condition characterized by a reduced sensitivity to glucocorticoids, which are steroid hormones involved in the regulation of various physiological processes, including the immune response, metabolism, and stress response. This condition results from mutations in the glucocorticoid receptor (GR), which impair the receptor's ability to bind glucocorticoids and mediate their effects.
Pathophysiology[edit]
The glucocorticoid receptor is a type of nuclear receptor that, upon binding to glucocorticoids, translocates to the cell nucleus and regulates the expression of target genes. In individuals with generalized glucocorticoid resistance, mutations in the GR gene lead to a decreased affinity for glucocorticoids or impaired receptor function. This results in a compensatory increase in the production of adrenocorticotropic hormone (ACTH) and cortisol, as the body attempts to overcome the resistance.
Clinical Features[edit]
Patients with generalized glucocorticoid resistance may present with a variety of symptoms due to the excess production of ACTH and cortisol. These can include:
- Hypertension
- Hypokalemia
- Fatigue
- Hirsutism
- Menstrual irregularities in females
- Precocious puberty in children
The severity of symptoms can vary widely among individuals, depending on the specific mutation and its impact on receptor function.
Diagnosis[edit]
Diagnosis of generalized glucocorticoid resistance involves a combination of clinical evaluation, laboratory testing, and genetic analysis. Key diagnostic steps include:
- Measurement of serum cortisol and ACTH levels, which are typically elevated.
- Assessment of glucocorticoid receptor function through in vitro assays.
- Genetic testing to identify mutations in the GR gene.
Treatment[edit]
Management of generalized glucocorticoid resistance focuses on alleviating symptoms and preventing complications. Treatment strategies may include:
- Administration of high doses of synthetic glucocorticoids to overcome receptor resistance.
- Use of mineralocorticoid receptor antagonists to manage hypertension and hypokalemia.
- Hormonal therapy to address menstrual irregularities and hirsutism.
Prognosis[edit]
The prognosis for individuals with generalized glucocorticoid resistance varies depending on the severity of the condition and the effectiveness of treatment. With appropriate management, many patients can lead relatively normal lives, although ongoing monitoring and treatment adjustments may be necessary.
